These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31200360)

  • 21. Multiple Approvals, Celestial Prices, Unimproved Outcomes: The Tale of Cost-Ineffective Drugs in Hepatocellular Carcinoma.
    Gyawali B
    J Natl Compr Canc Netw; 2019 Jun; 17(6):760-762. PubMed ID: 31200350
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmaceuticals and Medical Devices: Cost Savings.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-31. PubMed ID: 28252884
    [No Abstract]   [Full Text] [Related]  

  • 23. Expensive cancer therapies: unintended effects.
    Delude CM
    J Natl Cancer Inst; 2015 Jan; 107(1):497. PubMed ID: 25564602
    [No Abstract]   [Full Text] [Related]  

  • 24. Canadian Regulatory and Health Technology Assessment for Malignant Hematology and Oncology Indications Compared With the US Food and Drug Administration Accelerated Approval Program.
    Ho C; Lim HJ; Regier DA
    JAMA Netw Open; 2021 Aug; 4(8):e2120301. PubMed ID: 34379128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives on Cost and Value in Cancer Care.
    Saltz LB
    JAMA Oncol; 2016 Jan; 2(1):19-21. PubMed ID: 26501848
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost of Cancer Drugs: Something Has To Give.
    Bender E
    Manag Care; 2018 May; 27(5):18-22. PubMed ID: 29763403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innovative New Drugs for Serious Nonlethal Diseases: The Cost to Develop and the Cost to Buy.
    Eaglstein WH
    JAMA Dermatol; 2016 Feb; 152(2):139-40. PubMed ID: 26606648
    [No Abstract]   [Full Text] [Related]  

  • 28. Seeking value as cancer drug costs soar.
    Bender E
    Cancer Discov; 2013 Aug; 3(8):833-4. PubMed ID: 23928760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimalism in oncology.
    The Lancet Oncology
    Lancet Oncol; 2018 May; 19(5):579. PubMed ID: 29726372
    [No Abstract]   [Full Text] [Related]  

  • 30. Paying for Cancer Drugs That Prove Their Benefit.
    Frank RG; Emanuel EJ
    JAMA; 2021 Oct; 326(16):1579-1580. PubMed ID: 34633420
    [No Abstract]   [Full Text] [Related]  

  • 31. Should the American Society of Clinical Oncology Ask for Peer Review Before Publishing Its Advocacy Research?
    Bach PB
    J Clin Oncol; 2016 Dec; 34(36):4447-4448. PubMed ID: 27998217
    [No Abstract]   [Full Text] [Related]  

  • 32. Managed care & medical oncology: the focus is on value.
    Danielson E; Demartino J; Mullen JA
    J Natl Compr Canc Netw; 2010 Sep; 8 Suppl 7():S28-37. PubMed ID: 20947721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing Unfair Out-of-Network Billing - Integrated Approaches to Protecting Patients.
    Hall MA; Adler L; Ginsburg PB; Trish E
    N Engl J Med; 2019 Feb; 380(7):610-612. PubMed ID: 30650002
    [No Abstract]   [Full Text] [Related]  

  • 34. The Urgent Need in Oncology for a Comprehensive Cost of Care Task Force.
    Palmer JD; Patel TT; Fisher SA
    JAMA Oncol; 2018 Aug; 4(8):1045-1046. PubMed ID: 29931129
    [No Abstract]   [Full Text] [Related]  

  • 35. Improving outpatient oncology practice: several steps into a long journey.
    Conti RM; Bach PB
    J Oncol Pract; 2014 Nov; 10(6):355-6. PubMed ID: 25316027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use and coverage of novel cancer agents in managed care.
    Bailes JS
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):34-7. PubMed ID: 7992098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Keynote comment: Cancer drug pricing in the USA.
    Johnson DH
    Lancet Oncol; 2006 Jun; 7(6):444-5. PubMed ID: 16750490
    [No Abstract]   [Full Text] [Related]  

  • 38. The shortage of essential chemotherapy drugs in the United States.
    Gatesman ML; Smith TJ
    N Engl J Med; 2011 Nov; 365(18):1653-5. PubMed ID: 22040130
    [No Abstract]   [Full Text] [Related]  

  • 39. Putting a price on hope.
    Goozner M
    J Natl Cancer Inst; 2012 Sep; 104(17):1274-5. PubMed ID: 22914787
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral/infusion cancer drug parity begins to raise health plan costs.
    Carroll J
    Manag Care; 2012 Jan; 21(1):7-8. PubMed ID: 22334937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.